Comprehensive Medical Cannabis and Cannabinoid Education Presented at New York Expo
March 24th, 2017
Policy, Top News
Cannabis World Congress & Business Exposition (CWCBExpo) Partners with Healthway Education Systems to Offer CME Accredited Program for Healthcare Professionals
Educating medical practitioners about the cannabis plant’s potent treatment for a wide variety of medical conditions will be an all-day workshop offered at the Cannabis World Congress & Business Exposition (CWCBExpo) at the Javits Center in New York. Presented by Healthway Education Systems, Comprehensive Medical Cannabis and Cannabinoid Training will take place on Wednesday, June 14th and is a CME accredited program. The 4th Annual CWCBExpo, June 14-16, is the leading East Coast event for the medical marijuana, legalized cannabis and hemp industries.
The Comprehensive Medical Cannabis and Cannabinoid Training workshop will educate medical practitioners, including physicians, physician assistants, nurse practitioners, registered nurses, and pharmacists as well as industry professionals, on the advanced basic and clinical science of cannabinoids and medical cannabis.
The curriculum at CWCBExpo NY includes:
- Overview of the endocannabinoid system, synthetic cannabinoid and cannabis plant based preparations in management of neurological disorders, pain, and nausea
- Comparison of cannabinoid therapies with opioids
- Practical information on the existing legal medical cannabis products in the US and addiction and ethics of recommending medical cannabis
“This year, New York State added chronic pain as a qualifying condition and gave Physician’s Assistants and Nurse Practitioners authorization to write medical cannabis recommendations. CWCBExpo NY is the optimal location to provide healthcare professionals with the most advanced education and information on the cannabis plant. We look forward to educating the medical community and improving patient access to this treatment option,” said Scott Giannotti, Managing Director, CWCBExpo.
Michelle Lilly-Hester, Education Officer, added, “Healthway Education bridges the knowledge gap between state medical marijuana programs and medical professionals. We look forward to offering CWCBExpo NY attendees a world-class curriculum led by world class educators.”
CWCBExpo NY will also present a conference program (June 15-16) made up of curated panel presentations, lectures, and interactive discussions, covering the five main sectors of the cannabis industry: Cultivation, Processing, Sales, Ancillary Businesses, and Advocacy and Legislation. The CWCBExpo NY conference program will also offer headlining Keynote speakers and thought-leadership panels. Additional add-on workshops (June 14) include Make America Hemp Again; Following the Money in Cannabis: Where and How to Invest in the Cannabis Industry and Raise Capital for Your Cannabis Business; Open a Cannabis Business; and a bonus workshop on June 17th with 2 sessions on The Art of the Cannabis Sommelier: Interpening.
CWCBExpo NY, taking place under one roof in the financial and media capital of the world, will also host an expanded exhibit floor (June 15-16) with suppliers in the industry showcasing cutting-edge products and services to those in the business, entrepreneurs looking to enter the market, medical professionals, dispensary owners, retailers, investors, and providers of professional services. Featured exhibitors participating in the CWCBExpo NY include: Elixinol (Gold & Press Room Sponsor), Folium Biosciences (Exhibitor Product Theater Sponsor), Entourage Nutritional Distributors (Gold Sponsor), Greenspoon Marder (Lanyard Sponsor), CannaKorp (Badge Holder Insert Sponsor), and many more.
Advanced registration discounts are in effect now. For more information on the advance rates for CWCBExpo NY and to register visit: http://www.cwcbexpo.com/registration-new-york-2017/.
For more information on sponsoring or exhibiting at the coast-to-coast CWCBExpo events, contact Scott Giannotti, Managing Director at firstname.lastname@example.org or call 201-546-9161.
About Cannabis World Congress & Business Expositions (CWCBExpo)
The professionally run Cannabis World Congress & Business Expositions (CWCBExpo) are produced by Leading Edge Expositions in partnership with the International Cannabis Association (ICA). The events are the premier professional forums for dispensary owners, growers, suppliers, investors, medical professionals, government regulators, legal counsel, and entrepreneurs looking to achieve business success and identify new areas of growth in this dynamic industry. To learn more about the coast-to-coast CWCBExpos in New York, Los Angeles and Boston, go to www.cwcbexpo.com. Connect on Twitter/CWCBExpo, Facebook/CWCBExpo and Instagram/cwcbexpo.
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: http://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.